Nurix Therapeutics Inc (NRIX)
Who owns Nurix Therapeutics Inc (NRIX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.7% of the shares are freely tradable; institutional investors hold 115.0%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.63 | 8,925,642 | +0.6 | 03/31/2026 |
| Redmile Group, LLC | 7.48 | 7,732,808 | -4.5 | 03/31/2026 |
| Vestal Point Capital LP | 6.29 | 6,500,000 | +38.6 | 03/31/2026 |
| Deep Track Capital, LP | 6.14 | 6,345,244 | -9.8 | 03/31/2026 |
| Vanguard Group Inc | 5.75 | 5,949,512 | +32.5 | 12/31/2025 |
| FMR Inc | 5.36 | 5,541,271 | +30.9 | 03/31/2026 |
| State Street Corp | 4.97 | 5,141,195 | +44.4 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 4.77 | 4,931,999 | +1.0 | 03/31/2026 |
| Baker Bros Advisors LP | 4.51 | 4,658,556 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.28 | 4,427,112 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | van Houte Hans | Chief Financial Officer | Sell | 2,845 | 23.38 | 66,524 |
| 30. Jul 2026 | van Houte Hans | Chief Financial Officer | Other | 3,572 | 0.00 | – |
| 30. Jul 2026 | van Houte Hans | Chief Financial Officer | Other | 2,858 | 0.00 | – |
| 30. Jul 2026 | van Houte Hans | Chief Financial Officer | Other | 3,750 | 0.00 | – |
| 30. Jul 2026 | Ring Christine | Chief Legal Officer | Sell | 3,847 | 23.38 | 89,954 |
| 30. Jul 2026 | Ring Christine | Chief Legal Officer | Other | 3,572 | 0.00 | – |
| 30. Jul 2026 | Ring Christine | Chief Legal Officer | Other | 2,858 | 0.00 | – |
| 30. Jul 2026 | Ring Christine | Chief Legal Officer | Other | 3,750 | 0.00 | – |
| 30. Jul 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 3,847 | 23.38 | 89,954 |
| 30. Jul 2026 | Hansen Gwenn | Chief Scientific Officer | Other | 3,572 | 0.00 | – |
| 30. Jul 2026 | Hansen Gwenn | Chief Scientific Officer | Other | 2,858 | 0.00 | – |
| 30. Jul 2026 | Hansen Gwenn | Chief Scientific Officer | Other | 3,750 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.